The Wall Street Journal
@WSJ
Sign up for our newsletters and alerts: | Got a tip? | For WSJ customer support:
加入 April 2007
1.1K 正在關注 22.3M 粉絲
A committee said the volrustomig combination was unlikely to reach either of the primary endpoints for the trial, but the company said other Phase 3 volrustomig trials would continue as planned.
顯示更多
